These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12877350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.
    Farker K, Schotte U, Scheele J, Hoffmann A.
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):120-4. PubMed ID: 11911601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma.
    Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD.
    Am J Gastroenterol; 2003 Jun; 98(6):1417-22. PubMed ID: 12818290
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ.
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [Abstract] [Full Text] [Related]

  • 11. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.
    Agúndez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA, Benítez J.
    Pharmacogenetics; 1996 Dec; 6(6):501-12. PubMed ID: 9014199
    [Abstract] [Full Text] [Related]

  • 12. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S, Medeiros R, Vasconcelos A, Pinto D, Lopes C.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [Abstract] [Full Text] [Related]

  • 13. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY, Zhang WD, Chen YH, Zhang DX, Zhang YH.
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [Abstract] [Full Text] [Related]

  • 14. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T, Higaki Y, Hara M, Sakamoto T, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Kudo S, Tanaka K.
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [Abstract] [Full Text] [Related]

  • 15. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV, Kuligina ESh, Togo AV, Karpova MB, Ulibina JM, Shutkin VA, Hanson KP, Popowski K, Mosyagin I, Cascorbi I, Hirvonen A, Imyanitov EN.
    Cancer Lett; 2005 Apr 28; 221(2):177-83. PubMed ID: 15808403
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma].
    Gao JP, Huang YD, Lin JA, Zhu QC, Liang JP.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan 28; 11(1):20-2. PubMed ID: 12546735
    [Abstract] [Full Text] [Related]

  • 17. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA.
    Cancer Detect Prev; 2004 Jan 28; 28(3):187-93. PubMed ID: 15225898
    [Abstract] [Full Text] [Related]

  • 18. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F, Hou SM, Hemminki K, Lambert B, Pershagen G.
    Cancer Epidemiol Biomarkers Prev; 1998 Oct 28; 7(10):875-83. PubMed ID: 9796632
    [Abstract] [Full Text] [Related]

  • 19. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 28; 15(1):99-107. PubMed ID: 16434594
    [Abstract] [Full Text] [Related]

  • 20. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S, Deloménie C, Gallou C, Méjean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Béroud C, Dupret JM.
    Cancer Res; 1999 Jun 15; 59(12):2903-8. PubMed ID: 10383153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.